Disc Medicine (IRON) Profit After Tax Growth (1y) (2021 - 2026)
Disc Medicine (IRON) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
66.06% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
17.05% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-129.68% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-632.44% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Disc Medicine |
2.54 Bn |
1.81 Bn |
- |
-86.31% |
| Date | Value |
|---|
| Mar 31, 2026 |
-86.31% |
| Dec 31, 2025 |
-105.49% |
| Sep 30, 2025 |
-134.30% |
| Jun 30, 2025 |
-109.65% |
| Mar 31, 2025 |
-26.48% |
| Dec 31, 2024 |
-24.93% |
| Sep 30, 2024 |
-88.35% |
| Jun 30, 2024 |
-65.25% |
| Mar 31, 2024 |
-18.30% |
| Dec 31, 2023 |
-109.70% |
| Sep 30, 2023 |
12.56% |
| Jun 30, 2023 |
-66.46% |
| Mar 31, 2023 |
-131.21% |
| Dec 31, 2022 |
-162.20% |
| Sep 30, 2022 |
12.94% |
| Jun 30, 2022 |
41.75% |
| Mar 31, 2022 |
48.27% |
| Dec 31, 2021 |
2,324.88% |
| Sep 30, 2021 |
-85.45% |
| Jun 30, 2021 |
-1,096,366.67% |
